期刊文献+

人抵抗素基因全长的体外拼接及真核表达载体的构建

Assembly of full-length human resistin gene in vitro and construction of its eukaryotic expression vector
下载PDF
导出
摘要 目的:利用合成的寡核苷酸片段,在体外拼接人抵抗素(Resistin,Retn)基因的全长,并构建其真核表达载体。方法:根据已知抵抗素基因(GenBank:AF323081),设计并合成10条寡核苷酸片段,采用降落PCR方法进行拼接,获得预期大小的PCR产物后将其克隆入pSecTag2B载体进行测序确认。结果:降落PCR法扩增的特异条带与目的基因的大小一致。克隆载体测序结果与GenBank中已知序列完全符合。结论:降落PCR成功地拼接和扩增了人抵抗素全长基因,并构建了含有该基因的真核表达载体,为进一步研究该基因的功能奠定了实验基础。 Objective: To assemble the full-length of human resistin gene in vitro by using oligonucleotides and to construct its eukaryotic expression vector. Methods: According to the gene sequence of resistin (GenBank: AF323081), 10 oligonucleotides were designed and synthesized,followed by a touch down PCR to assemble the full-length gene. The PCR products were cloned into pSecTag2B vector and confirmed by sequencing. Results: The band of PCR products and gene sequencing showed the insert fragment in pSecTag2B vector was identical to that as designed. Conclusion: The full-length of human resistin coding sequence was successfully assembled and amplified by touch down PCR, and a resistin-expressing eukaryotic vector was constructed.
出处 《浙江大学学报(医学版)》 CAS CSCD 2007年第6期588-591,609,共5页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省科技厅科研基金资助项目(2003C33031)
关键词 激素类 异位 寡核苷酸类 聚合酶链反应 基因扩增 人Resistin基因 降落PCR 表达载体 Hormones, ectopic Oligonucleotides Polymerase chain reaction Gene amplification Resistin gene Touch down PCR Expression vector
  • 相关文献

参考文献2

二级参考文献27

  • 1Steppan CM, Bailey ST, Bhat S, Briwn EJ, Baberjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
  • 2Rajala MW, Lin Y, Ranalletta M, Yanq XM, Qian H, Ginqerich R, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue.Mol Endocrinol 2002; 16: 1920-30.
  • 3Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
  • 4Rajala MW, Qi Y, Patel HR, Takahashi N, Baberjee R, Pajvani UB, et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004; 53: 1671-9.
  • 5Ghosh S, Singh AK, Aruna B, Mukhopadhyay S, Ehtesham NZ.The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 2003; 305: 27-34.
  • 6Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med 2004; 1: e45.
  • 7Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerrk K, Jones R, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88: 5452-5.
  • 8McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A,McTernan CL, et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098-106.
  • 9Bajaj M, Suraamornkul S, Hardies LJ, Pratipanaeatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type Ⅱ diabetic patients. Int J Obes Relat Metab Disord 2004;28: 783-9.
  • 10McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol 2006; 17: 170-5.

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部